Healthcare Mergers & Acquisitions (M&A) Consulting Services

There is a potential mergers and acquisitions (M&A) market of almost $500 billion. With our assistance, you may reduce the time it takes to search a market and release your product.

Get Started

Healthcare Mergers & Acquisitions Consulting

Healthcare Mergers and Acquisitions Consulting Services

What sets us apart is that our teams are heavily rooted in the process lifecycle, and we believe in providing comprehensive services to mergers and acquisitions businesses. Our customers benefit from the healthcare mergers and acquisitions consulting team’s expertise in data collection, strategy development, and the dissemination of peer deal alerts. Market projections, technological information, and therapeutic content are areas where our experts will assist you. The investment research team at SG Analytics (SGA) works closely with the life sciences and healthcare business insights team to provide you with the necessary due diligence.

Healthcare M&A Consulting Services

Merger and acquisition (M&A) organizations and venture capitalists (VCs) in the pharmaceutical, life sciences, and devices industries always search for innovative technologies and prospective acquirers from developing and developed countries. So, we excel at spotting and analyzing new medical technologies, patent cliffs, patent disputes, new FDA and ANDA filings, peer competition, and more.

Why SGA

Industry Leader

SGA thrives by its brand promise Lifes Possible and is recognized as the trusted life sciences & healthcare business consulting and services provider company in the U.S.

12+ Languages

Multilingual capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English (U.S. & U.K.) experts (either in-house or partnerships).

Data-Driven Insights

With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.

End-To-End Solutioning

The in-house KOL capability of more than 700, along with the in-house capabilities of primary market research, financial research, data analytics, data engineering, IT, and ESG research and consulting, helps to present credible competitive information.

Who We Work With

Medical Devices

We support new product entries, competitive intelligence (CI), and market intelligence teams with relevant information.

Pharmaceuticals & Biopharma

We support pharma and biopharma market intelligence, strategy, sales, marketing, and R&D teams in developed and developing markets.

Mergers and Acquisition Analysis

We support M&A firms with product portfolio fitment analysis, patents and clinical trial data, pipeline analysis, and short listing of healthcare acquirer and acquire prospects.

Private Equity, Investment Banks, and Investor Community

We support financial firms with ad-hoc and white-labeled research comprising industry analysis, primary research, and CI intel from major markets.

Animal Health

We offer market intelligence on veterinary products and equipment and help mid-senior management with relevant data.

In Vitro Diagnostics

We track diagnostics kits, reagents, and equipment, which help marketing and sales teams with market penetration efforts. Our services are preferred by product managers and marketing leaders.

Life Sciences & Healthcare IT

We offer technology tracking services, market sizing and forecasting, and primary market research involving healthcare payers and providers and product launch information to life sciences & healthcare IT leaders of the world.

Life Sciences Consulting & Information Service Providers

We have run off-shored capability centers of ISPs, with a record of tracking >5,000 pharmaceutical companies and supporting their onshore teams to track markets and create analyses.